1. Sperling RA, Gil P, Zhang F, Zanella M, Parak WJ: Biological applications of
gold nanoparticles. Chem Soc Rev 2008, 37(9):1896–1908.
2. Boisselier E, Astruc D: Gold nanoparticles in nanomedicine: preparation,
imaging, diagnostics, therapies and toxitiy. Chem Soc Rev 2009,
38(6):1759–1782.
3. Sopjani M, Föller M, Lang F: Gold stimulates Ca2+ entry into and
subsequent suicidal death of erythrocytes. Toxicology 2008, 244:271–279.
4. Sereemaspun A, Rojanathanes R, Wiwanitkit V: Effect of gold nanoparticle
on renal cell: an implication for exposure risk. Renal failure 2008,
30:323–325.
5. Cho W-S, Cho M, Jeong J, Choi M, Cho H-Y, Han BS, Kim SH, Kim HO,
Lim YT, Chung BH, Jeong J: Acute toxicity and pharmacokinetics of
13 nm-sized PEG-coated gold nanoparticles. Toxicology and Applied
Pharmacology 2009, 236(1):16–24.
6. Gibson MI, Danial M, Klok H-A: Sequentially Modified, Polymer-Stabilized
Gold Nanoparticle Libraries: Convergent Synthesis and Aggregation
Behavior. ACS Combinatorial Science 2011, 13(3):286–297.
7. Pan Y, Leifert A, Ruau D, Neuss S, Bornemann J, Schmid G, Brandau W,
Simon U, Jahnen-Dechent W: Gold nanoparticles of diameter 1.4 nm
trigger necrosis by oxidative stress and mitochondrial damage. Small
(Weinheim an der Bergstrasse, Germany) 2009, 5:2067–2076.
8. Arvizo RR, Miranda OR, Thompson MA, Pabelick CM, Bhattacharya R,
Robertson JD, Rotello VM, Prakash YS, Mukherjee P: Effect of nanoparticle
surface charge at the plasma membrane and beyond. Nano letters 2010,
10:2543–2548.
9. Hauck TS, Ghazani AA, Chan WCW: Assessing the effect of surface
chemistry on gold nanorod uptake, toxicity, and gene expression in
mammalian cells. Small (Weinheim an der Bergstrasse, Germany) 2008,
4:153–159.
10. Uboldi C, Bonacchi D, Lorenzi G, Hermanns MI, Pohl C, Baldi G, Unger RE,
Kirkpatrick CJ: Gold nanoparticles induce cytotoxicity in the alveolar
type-II cell lines A549 and NCIH441. Part Fibre Toxicol 2009, 6:18.
11. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP,
Pober JS, Wick TM, Konkle BA, Schwartz BS, et al: Endothelial cells in
physiology and in the pathophysiology of vascular disorders. Blood 1998,
91:3527–3561.
12. Kirkpatrick CJ, Bittinger F, Klein CL, Hauptmann S, Klosterhalfen B: The role
of the microcirculation in multiple organ dysfunction syndrome (MODS):
a review and perspective. Virchows Arch 1996, 427:461–476.
13. Kunzmann A, Andersson B, Thurnherr T, Krug H, Scheynius A, Fadeel B:
Toxicology of engineered nanomaterials: Focus on biocompatibility,
biodistribution and biodegradation. Biochimica et biophysica acta 2010,
1810(3):361–73.
14. Bartczak D, Sanchez-Elsner T, Louafi F, Millar TM, Kanaras AG: Receptor-
Mediated Interactions between Colloidal Gold Nanoparticles and Human
Umbilical Vein Endothelial Cells. Small 2010, 7(3):388–94.
15. Bartczak D, Muskens OL, Nitti S, Sanchez-Elsner T, Millar TM, Kanaras AG:
Interactions of Human Endothelial Cells with Gold Nanoparticles of
Different Morphologies. Small 2012, 8:122–130.
16. Chithrani BD, Ghazani AA, Chan WCW: Determining the Size and Shape
Dependence of Gold Nanoparticle Uptake into Mammalian Cells. Nano
Letters 2006, 6:662–668.
17. Ma Y-J, Gu H-C: Study on the endocytosis and the internalization
mechanism of aminosilane-coated Fe3O4 nanoparticles in vitro. Journal
of materials science Materials in medicine 2007, 18:2145–2149.
18. Nativo P, Prior IA, Brust M: Uptake and Intracellular Fate of Surface-Modified
Gold Nanoparticles. ACS Nano 2008, 2:1639–1644.
19. Scholzen T, Gerdes J: The Ki-67 protein: from the known and the
unknown. Journal of cellular physiology 2000, 182:311–322.
20. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H: Cell cycle
analysis of a cell proliferation-associated human nuclear antigen defined
by the monoclonal antibody Ki-67. Journal of immunology (Baltimore, Md:
1950) 1984, 133:1710–1715.
21. Sasaki K, Murakami T, Kawasaki M, Takahashi M: The cell cycle associated
change of the Ki-67 reactive nuclear antigen expression. Journal of
cellular physiology 1987, 133:579–584.
22. Dyer LA, Patterson C: Development of the endothelium: an emphasis on
heterogeneity. Seminars in thrombosis and hemostasis 2010, 36:227–235.
23. Mironava T, Hadjiargyrou M, Simon M, Jurukovski V, Rafailovich MH: Gold
nanoparticles cellular toxicity and recovery: Effect of size, concentration
and exposure time: Nanotoxicology. Nanotoxicology 2010, 4:120–137.
24. Roa W, Zhang X, Guo L, Shaw A, Hu X, Xiong Y, Gulavita S, Patel S, Sun X,
Chen J, et al: Gold nanoparticle sensitize radiotherapy of prostate cancer
cells by regulation of the cell cycle. Nanotechnology 2009, 20:375101.
25. Fang JL, Beland FA: Long-term exposure to zidovudine delays cell cycle
progression, induces apoptosis, and decreases telomerase activity in
human hepatocytes. Toxicol Sci 2009, 111:120–130.
26. Zhang L, Zhang J, Hu C, Cao J, Zhou X, Hu Y, He Q, Yang B: Efficient
activation of p53 pathway in A549 cells exposed to L2, a novel
compound targeting p53-MDM2 interaction. Anticancer Drugs 2009,
20:416–424.
27. Gosens I, Post JA, de la Fonteyne LJ, Jansen EH, Geus JW, Cassee FR,
de Jong WH: Impact of agglomeration state of nano- and submicron
sized gold particles on pulmonary inflammation. Part Fibre Toxicol 2010,
7:37.
28. Nel AE, Madler L, Velegol D, Xia T, Hoek EMV, Somasundaran P, Klaessig F,
Castranova V, Thompson M: Understanding biophysicochemical
interactions at the nano-bio interface. Nat Mater 2009, 8:543–557.
29. Pan Y, Neuss S, Leifert A, Fischler M, Wen F, Simon U, Schmid G, Brandau W,
Jahnen-Dechent W: Size-Dependent Cytotoxicity of Gold Nanoparticles.
Small 2007, 3:1941–1949.
30. Rothen-Rutishauser B, Mühlfeld C, Blank F, Musso C, Gehr P: Translocation
of particles and inflammatory responses after exposure to fine
particles and nanoparticles in an epithelial airway model. Part Fibre
Toxicol 2007, 4:9.
31. Xia T, Kovochich M, Liong M, Zink JI, Nel AE: Cationic Polystyrene
Nanosphere Toxicity Depends on Cell-Specific Endocytic and
Mitochondrial Injury Pathways. ACS Nano 2008, 2:85–96.
32. Unger RE, Krump-Konvalinkova V, Peters K, Kirkpatrick CJ: In Vitro
Expression of the Endothelial Phenotype: Comparative Study of
Primary Isolated Cells and Cell Lines, Including the Novel Cell Line
HPMEC-ST1.6R. Microvascular Research 2002, 64:384–397.
33. Weksler BB, Subileau EA, Perrière N, Charneau P, Holloway K, Leveque M,
Tricoire-Leignel H, Nicotra A, Bourdoulous S, Turowski P, et al: Blood–brain
barrier-specific properties of a human adult brain endothelial cell line.
The FASEB journal: official publication of the Federation of American Societies
for Experimental Biology 2005, 19:1872–1874.